+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sterile Vacuum Blood Collection Tube Market by Additive Type, End User, Application, Closure Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6079985
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Redefining Blood Collection in a Shifting Healthcare Ecosystem

The sterile vacuum blood collection tube sits at the heart of modern clinical diagnostics, serving as the critical interface between patient sampling and laboratory analysis. Its precision-engineered design ensures sample integrity, minimizes contamination risks, and streamlines workflow in high-volume environments. As healthcare systems worldwide embrace more rigorous quality standards and faster turnaround times, these tubes have become indispensable for accurate and timely diagnostic outcomes.

In recent years, demand has surged in response to expanding screening programs, growing chronic disease burdens, and a shift toward preventive care models. Laboratories and hospitals are evaluating solutions that offer consistent vacuum levels, reliable closure mechanisms, and compatibility with automated processing equipment. Meanwhile, stringent regulations around sterility and biocompatibility have raised the bar for manufacturers, driving continuous innovation in materials science and production methodologies.

Against this backdrop, stakeholders must understand the interplay of technological advancements, regulatory frameworks, and market dynamics that shape product development and adoption. This report introduces the key factors influencing this specialized market, setting the stage for an in-depth examination of transformative trends, trade policy shifts, and segmentation insights that impact strategic decision-making.

Breakthrough Innovations Driving Sterile Vacuum Tube Evolution

A wave of transformative innovations is reshaping the sterile vacuum tube landscape, propelled by breakthroughs in additive engineering, closure designs, and manufacturing automation. Material scientists are developing novel polymer blends that enhance barrier properties and reduce leachables, thereby improving sample stability during transport and storage. Simultaneously, next-generation closure technologies incorporate precision molding and advanced gasket formulations to ensure leak-proof performance under extreme conditions.

Automation plays an equally pivotal role. High-throughput filling lines equipped with robotic handling and inline quality inspection have reduced variability and elevated production efficiency. Integrated data capture systems now enable real-time traceability of each tube’s batch history, reinforcing compliance with rigorous regulatory standards and supporting robust post-market surveillance.

On the diagnostic front, there is a growing emphasis on tubes tailored to specific analytical workflows. Separator gels with optimized density facilitate rapid plasma-serum separation, while specialized clot activators improve coagulation kinetics for certain assays. These targeted solutions not only enhance laboratory productivity but also open new avenues for point-of-care applications, further extending the utility of vacuum tubes across diverse clinical settings.

Assessing the 2025 US Tariff Wave on Supply Chains and Cost Structures

The imposition of new United States tariffs in 2025 has introduced a complex layer of cost considerations for manufacturers and end users of sterile vacuum blood collection tubes. Sourced materials such as high-grade polymers and specialized additives face elevated import duties, exerting upward pressure on production expenses. As a result, cost structures across global supply chains have been reshaped, prompting strategic responses from both suppliers and buyers.

Some manufacturers have accelerated efforts to develop domestic material sources or relocate key production steps to tariff-neutral regions, seeking to mitigate the impact on margins. Others have renegotiated supplier contracts or invested in alternative formulations that remain compliant with quality standards while reducing overall input costs. Buyers, particularly large laboratory networks and hospital systems, are reevaluating procurement strategies to secure favorable pricing and consistent supply.

These shifts have produced ripple effects throughout the value chain. Distributors have adjusted inventory policies to buffer against price volatility, and service providers offering tube reprocessing or refurbishment have seen increased interest as cost containment measures gain prominence. Navigating this evolving trade environment requires an agile approach that blends supply chain diversification with diligent cost management.

Deep Dive into Market Segments Reveals Strategic Growth Levers

A thorough examination of market segments uncovers distinct growth drivers and innovation opportunities across additive types, end users, applications, and closure technologies. When analyzing tubes by additive type, the anticoagulant segment emerges as particularly dynamic, encompassing citrate preparations, EDTA variants subdivided into K2-EDTA and K3-EDTA, and multiple heparin formulations such as ammonium, lithium, and sodium heparins, along with oxalate, clot activators, tubes with no additives, and separator gels engineered for rapid phase separation. This diversity reflects laboratories’ requirements for targeted performance characteristics aligned with specific assay protocols.

Looking at end users reveals that diagnostic laboratories-both hospital-affiliated and independent-drive substantial volume growth, while hospital laboratories in private and public settings continue to demand large, consistent shipments. Blood banks maintain steady consumption, and research institutes leverage specialized tubes for advanced biomarker discovery and translational studies. The interplay among these segments underscores the need for versatile product portfolios that can address varied throughput, regulatory compliance, and cost considerations.

Applications further segment the market into blood donation, clinical diagnostic workflows in biochemistry, hematology, immunology, and research applications, each with unique quality and performance benchmarks. Finally, closure technologies categorized by push-stop and screw-top designs cater to user preferences for ease of use, automation compatibility, and leak-proof reliability. Recognizing the nuanced requirements within each segment enables companies to align R&D investments and marketing strategies for maximum impact.

Regional Dynamics Shaping Global Demand Patterns

Regional dynamics play a decisive role in shaping global demand and competitive positioning. In the Americas, advanced healthcare infrastructure and high per-capita testing rates underpin robust consumption of sterile vacuum tubes. The introduction of elevated tariff rates has prompted local manufacturers to scale up capacity, reducing reliance on imports and fostering innovation in domestic production capabilities.

Within Europe, Middle East & Africa, regulatory harmonization efforts in the European Union contrast with emerging frameworks in the Middle East and Africa, where investment in diagnostic infrastructure is gaining momentum. Key markets in this region exhibit strong growth potential as governments prioritize healthcare modernization and expand public-private partnerships to enhance laboratory services.

Asia-Pacific stands out for its rapid expansion in diagnostic testing and clinical research. Low-cost manufacturing hubs have bolstered supply, while rising per-patient screening rates in countries across Southeast Asia, South Asia, and Oceania have driven demand. At the same time, local regulations and quality standards are evolving, prompting both global and regional players to adapt their product offerings to comply with diverse certification requirements and meet the expectations of cost-conscious healthcare providers.

Competitive Landscape Highlights Leading Industry Players

The competitive landscape is characterized by a concentration of established manufacturers alongside emerging specialized players. Leading companies differentiate through proprietary polymer formulations, patented closure systems, and integrated automation solutions that address the full spectrum of laboratory workflows. Strategic partnerships with reagent suppliers and diagnostic equipment vendors have strengthened product ecosystems, reinforcing customer loyalty and creating barriers to entry.

Several players are actively pursuing mergers and acquisitions to broaden geographic reach and enhance vertical integration, securing access to raw materials and reducing exposure to tariff fluctuations. Others are investing in capacity expansions at state-of-the-art facilities equipped with cleanroom environments and real-time quality monitoring. These investments not only raise the quality bar but also accelerate time-to-market for novel tube designs and specialty applications.

Furthermore, sustainability initiatives are gaining traction as end users prioritize eco-friendly materials and circular economy principles. Manufacturers that integrate recyclable plastics, reduce packaging waste, and establish tube reprocessing programs are positioning themselves favorably in procurement evaluations by leading healthcare networks.

Strategic Imperatives for Market Leaders to Drive Sustainable Growth

To capitalize on market opportunities and address evolving challenges, industry leaders should prioritize a multi-pronged strategy. First, investing in advanced closure technologies will enhance sample integrity, reduce the risk of cross-contamination, and support high-speed automation lines. Second, diversifying the supply chain through partnerships or localized production can mitigate the impact of trade policy shifts and safeguard continuity of supply.

Tailoring product portfolios to the nuanced needs of diagnostic laboratories, hospital systems, blood banks, and research institutions is essential. This requires close engagement with end users to identify performance gaps and co-develop customized solutions. Digital integration of traceability data and quality metrics will further differentiate offerings, fostering customer loyalty and supporting compliance initiatives.

Embracing sustainability through the adoption of recyclable polymers, reduced packaging, and tube reprocessing programs can unlock procurement advantages, especially among health systems with aggressive environmental targets. Finally, leveraging market intelligence and scenario planning to anticipate regulatory changes and tariff adjustments will enable proactive adaptation of manufacturing footprints and pricing models.

Robust Research Framework Ensures Comprehensive Market Understanding

The research methodology underpinning this analysis combines rigorous primary and secondary approaches to ensure robustness and reliability. Primary research involved in-depth interviews with key stakeholders, including laboratory directors, procurement managers, polymer scientists, and regulatory experts. These conversations provided qualitative insights into performance expectations, purchasing drivers, and adoption challenges faced across various healthcare settings.

Secondary research entailed an exhaustive review of industry publications, regulatory filings, patent databases, and trade statistics to capture the latest technological developments and policy updates. Data triangulation techniques were applied to validate findings, reconciling information from multiple sources to arrive at a coherent narrative.

Segmentation analyses were performed using a bottom-up approach, dissecting markets by additive type, end user, application, and closure technology to identify volume and value dynamics. Regional evaluations incorporated socioeconomic indicators, healthcare expenditure metrics, and tariff schedules to contextualize demand patterns and cost implications. The resulting framework delivers a comprehensive snapshot of the sterile vacuum tube market without relying on speculative forecasting.

Synthesis of Insights Illuminates Path Forward in Vacuum Tube Market

The sterile vacuum blood collection tube market stands at a pivotal juncture, shaped by technological innovation, evolving regulatory landscapes, and dynamic trade policies. Innovations in additive chemistry and closure systems are enhancing sample integrity and processing efficiency, while automation continues to drive operational excellence in laboratories worldwide.

Simultaneously, the 2025 United States tariffs have underscored the importance of supply chain agility and cost diversification. Manufacturers that adapt by localizing production or optimizing material sourcing are well positioned to maintain competitive pricing and reliable delivery. Detailed segmentation insights reveal that tailored solutions across anticoagulant types, end-user categories, clinical and research applications, and closure designs offer clear pathways for targeted growth.

Regional disparities, from mature markets in the Americas to emerging opportunities in Europe, the Middle East & Africa, and Asia-Pacific, highlight the need for differentiated go-to-market strategies. In this landscape, companies that combine strategic investments in R&D, sustainable practices, and customer-centric service models will secure leadership positions and drive long-term value.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Additive Type
    • Anticoagulant
      • Citrate
      • Edta
        • K2-Edta
        • K3-Edta
      • Heparin
        • Ammonium Heparin
        • Lithium Heparin
        • Sodium Heparin
      • Oxalate
    • Clot Activator
    • No Additive
    • Separator Gel
  • End User
    • Blood Banks
    • Diagnostic Laboratories
      • Hospital-Affiliated Laboratories
      • Independent Laboratories
    • Hospital Laboratories
      • Private Hospitals
      • Public Hospitals
    • Research Institutes
  • Application
    • Blood Donation
    • Clinical Diagnosis
      • Biochemistry
      • Hematology
      • Immunology
    • Research Applications
  • Closure Technology
    • Push Stop
    • Screw Top
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Becton, Dickinson and Company
  • Greiner Bio-One International GmbH
  • Terumo Corporation
  • Sarstedt AG & Co. KG
  • HTL-STREFA S.A.
  • Kabe Labortechnik GmbH & Co. KG
  • Nipro Corporation
  • Antylia Scientific Inc.
  • Macherey-Nagel GmbH & Co. KG
  • Jiangsu Kangning Medical Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sterile Vacuum Blood Collection Tube Market, by Additive Type
8.1. Introduction
8.2. Anticoagulant
8.2.1. Citrate
8.2.2. Edta
8.2.2.1. K2-Edta
8.2.2.2. K3-Edta
8.2.3. Heparin
8.2.3.1. Ammonium Heparin
8.2.3.2. Lithium Heparin
8.2.3.3. Sodium Heparin
8.2.4. Oxalate
8.3. Clot Activator
8.4. No Additive
8.5. Separator Gel
9. Sterile Vacuum Blood Collection Tube Market, by End User
9.1. Introduction
9.2. Blood Banks
9.3. Diagnostic Laboratories
9.3.1. Hospital-Affiliated Laboratories
9.3.2. Independent Laboratories
9.4. Hospital Laboratories
9.4.1. Private Hospitals
9.4.2. Public Hospitals
9.5. Research Institutes
10. Sterile Vacuum Blood Collection Tube Market, by Application
10.1. Introduction
10.2. Blood Donation
10.3. Clinical Diagnosis
10.3.1. Biochemistry
10.3.2. Hematology
10.3.3. Immunology
10.4. Research Applications
11. Sterile Vacuum Blood Collection Tube Market, by Closure Technology
11.1. Introduction
11.2. Push Stop
11.3. Screw Top
12. Americas Sterile Vacuum Blood Collection Tube Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Sterile Vacuum Blood Collection Tube Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Sterile Vacuum Blood Collection Tube Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Becton, Dickinson and Company
15.3.2. Greiner Bio-One International GmbH
15.3.3. Terumo Corporation
15.3.4. Sarstedt AG & Co. KG
15.3.5. HTL-STREFA S.A.
15.3.6. Kabe Labortechnik GmbH & Co. KG
15.3.7. Nipro Corporation
15.3.8. Antylia Scientific Inc.
15.3.9. Macherey-Nagel GmbH & Co. KG
15.3.10. Jiangsu Kangning Medical Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. STERILE VACUUM BLOOD COLLECTION TUBE MARKET MULTI-CURRENCY
FIGURE 2. STERILE VACUUM BLOOD COLLECTION TUBE MARKET MULTI-LANGUAGE
FIGURE 3. STERILE VACUUM BLOOD COLLECTION TUBE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. STERILE VACUUM BLOOD COLLECTION TUBE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. STERILE VACUUM BLOOD COLLECTION TUBE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STERILE VACUUM BLOOD COLLECTION TUBE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY K2-EDTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY K3-EDTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY AMMONIUM HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY LITHIUM HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY SODIUM HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY OXALATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOT ACTIVATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY SEPARATOR GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL-AFFILIATED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD DONATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY PUSH STOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY SCREW TOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 69. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 70. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 71. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 73. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 74. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 76. CANADA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 79. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 80. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 81. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 83. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 84. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 130. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 131. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 132. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 134. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 135. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 137. GERMANY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 139. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 140. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 141. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 142. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 144. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 145. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 160. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 161. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 162. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 164. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 165. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 167. ITALY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 170. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 171. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 172. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 174. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 175. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 177. SPAIN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 209. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 210. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 211. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 212. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 214. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 215. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 217. DENMARK STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 229. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 230. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 231. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 232. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 234. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 235. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 237. QATAR STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 239. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 240. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 241. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 242. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 244. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 245. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 247. FINLAND STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 269. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 270. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 271. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 272. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 274. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 275. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 277. EGYPT STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 279. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANTICOAGULANT, 2018-2030 (USD MILLION)
TABLE 280. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 281. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, 2018-2030 (USD MILLION)
TABLE 282. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 285. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 287. TURKEY STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE TYPE, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL STERILE VACUUM BLOOD COLLECTION TUBE MARKET SIZE, BY ANT

Companies Mentioned

The companies profiled in this Sterile Vacuum Blood Collection Tube market report include:
  • Becton, Dickinson and Company
  • Greiner Bio-One International GmbH
  • Terumo Corporation
  • Sarstedt AG & Co. KG
  • HTL-STREFA S.A.
  • Kabe Labortechnik GmbH & Co. KG
  • Nipro Corporation
  • Antylia Scientific Inc.
  • Macherey-Nagel GmbH & Co. KG
  • Jiangsu Kangning Medical Co., Ltd.

Methodology

Loading
LOADING...